Brian Casey and Kate Madden Yee

Clinical News
Breast screening critics Gotzsche, Welch lose positions
Last week was a bad one for opponents of breast cancer screening. On Saturday, prominent screening opponent Dr. Peter Gøtzsche was booted from the governing board of the Cochrane just days after screening skeptic Dr. H. Gilbert Welch resigned from Dartmouth College over plagiarism allegations.
September 16, 2018
2016 08 18 13 26 22 430 Breast Screening Mammo 400
Conference
Canon launches new 1.5-tesla MRI, US unit at ECR
VIENNA - Canon Medical Systems is making its first appearance at ECR 2018 under a unified banner since Canon took over Toshiba Medical Systems. The firm has a full slate of product launches, including Vantage Orian, a new 1.5-tesla MRI scanner.
February 28, 2018
2018 03 01 23 32 8419 Canon Vantage Orian 20180301231927
Page 1 of 1
Top Stories
Global Pharmaceutical Trade Network Adobe Tida
Womens Imaging
What’s the likely impact of €16B Hologic deal?
Private equity firms are acquiring women’s health vendor Hologic. Senior industry experts reflect on the deal and the future consequences for the global women’s health sector.
Dedicated breast F-18 FDG PET/MRI exam pre- (A, D, G), mid- (B, E, H), and post-NAC (C, F, I) of a 41-year-old patient diagnosed with a triple negative (TN), grade 2, invasive carcinoma. The SUVmax values of the primary tumor were 14.68 pre-NAC, 1.69 mid-NAC, and 1.87 post-NAC, while SER values were 1.19, 0.52, and 0.63, respectively. Figure courtesy of Melissa Lenaerts, PhD, Dr. Thiemo van Nijnatten, PhD, et al and presented at EUSOBI 2025.
Molecular Imaging
PET/MRI begins to deliver in breast cancer
A 399 Fig 2 Pem Vs Cesm E Poster Eusobi 2025 Deabes Thumbnail
Molecular Imaging
EUSOBI: Positron emission mammography demonstrates worth
2025 10 20 Eanm Early Perfusion Imaging Fig1 Thumbnail
Molecular Imaging
Amyloid PET can track patterns of neurodegeneration
Join Us!
Sponsor Content
Join Us!
More in Home
What’s the likely impact of €16B Hologic deal?
By Erik L. Ridley and Philip Ward
Private equity firms are acquiring women’s health vendor Hologic. Senior industry experts reflect on the deal and the future consequences for the global women’s health sector.
October 23, 2025
Global Pharmaceutical Trade Network Adobe Tida
PET/MRI begins to deliver in breast cancer
By Philip Ward
The clinical role of PET/MRI is evolving rapidly in breast cancer, according to two studies presented at the European Society of Breast Imaging annual meeting.
October 23, 2025
Dedicated breast F-18 FDG PET/MRI exam pre- (A, D, G), mid- (B, E, H), and post-NAC (C, F, I) of a 41-year-old patient diagnosed with a triple negative (TN), grade 2, invasive carcinoma. The SUVmax values of the primary tumor were 14.68 pre-NAC, 1.69 mid-NAC, and 1.87 post-NAC, while SER values were 1.19, 0.52, and 0.63, respectively. Figure courtesy of Melissa Lenaerts, PhD, Dr. Thiemo van Nijnatten, PhD, et al and presented at EUSOBI 2025.
EUSOBI: Positron emission mammography demonstrates worth
By Edna Astbury-Ward, PhD
Positron emission mammography is proving useful in the presurgical assessment of invasive lobular carcinoma, researchers reported at the European Society of Breast Imaging (EUSOBI) annual meeting.
October 22, 2025
A 399 Fig 2 Pem Vs Cesm E Poster Eusobi 2025 Deabes Thumbnail
Amyloid PET can track patterns of neurodegeneration
By Maryam Payne
Early perfusion amyloid-PET shows potential for diagnosing and monitoring neurodegenerative disease and has possible advantages over FDG-PET scanning.
October 22, 2025
2025 10 20 Eanm Early Perfusion Imaging Fig1 Thumbnail
The epidemic of decision paralysis
By Dr. Paul McCoubrie
Decision-making is central to successful clinical practice, but no one seems to make decisions these days, writes Dr. Paul McCoubrie in the second part of his series about interactions between surgeons and radiologists.
October 21, 2025
Paul Mc Coubrie April 24
Global survey pinpoints key trends in spectral CT
By Liz Carey
The use of spectral CT is rising, but its clinical integration and quality assurance/quality control practices are inconsistent, the International Atomic Energy Agency has found.
October 20, 2025
Ct Scan Tech Adobe Stock By Peakstock g3ma9suare
Abnormal CT-FFR results translate to up to 7 years' cardiac risk
By Kate Madden Yee
The prognostic value of CT fractional flow reserve (CT-FFR) has been unclear, but the findings of a recent study from Denmark offer further insight.
October 20, 2025
Heart Damage
Transgender breast care emerges as priority for radiology
By Frances Rylands-Monk
Radiology needs to stop thinking of breast cancer as a disease that only concerns women and do much more to include transgender patients in breast care, says Dr. Anna D'Angelo from Rome.
October 20, 2025
Anna Portrait
Hot shots from Istanbul: Report from ESNR 2025
By Dr. Gennaro D'Anna
Radiologist Dr. Gennaro D'Anna provides a roundup and collection of images from the 48th annual meeting of the European Society of Neuroradiology (ESNR).
October 17, 2025
Istanbul Congress Center
PI-RADS v2.1 is 'highly sensitive' for prostate cancer detection on MRI
By Kate Madden Yee
PI-RADS v2.1 shows high sensitivity for categorizing clinically significant prostate cancer on MRI at both the patient and lesion levels, German researchers have found.
October 16, 2025
Benign Prostatic Hyperplasia
Breast CT gains clinical momentum in Europe
By Philip Ward
Dedicated contrast-enhanced breast CT is advancing as a clinical tool, but variations persist in acquisition protocols, particularly the timing of contrast administration. Dutch researchers have tried to resolve this issue.
October 16, 2025
Woman Lying On Ct Scanner Adobe Lasgkhidzetim
Belgian study shows AI's promise in coronary ischemia
By Maryam Payne
A deep-learning model for assessing vessel-specific coronary ischemia performed well compared to invasive fractional flow reserve in a multicenter study published by European Radiology on 11 October.
October 15, 2025
2025 10 11 Er Peters Fig3 Thumbnail
Page 1 of 61
Next Page